Cyclic On-off Switching of Pulmonary Blood Flow in Moderate to Severe ARDS
NCT ID: NCT07327268
Last Updated: 2026-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
40 participants
OBSERVATIONAL
2026-01-01
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Driving Pressure Guided VT in ARDS Patients
NCT05207267
Effect of EIT-guided PEEP Titration on the Prognosis of Patients with Moderate to Severe ARDS
NCT05207202
Physiological Effects of Lung Impedance Tomography-Guided and Plat Pressure-Guided Phigh During APRV in Patients With ARDS
NCT06696638
Improvement of ARDS Ventilation-perfusion Matching by Prone Positioning Assessed by EIT
NCT05765760
Electrical Impedance Tomography-Based Prognostic Model for ARDS
NCT06967207
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
phase 1
patients ventilated with a tidal volume of 4ml/kg pbw
No interventions assigned to this group
phase 2
patients ventilated with a tidal volume of 6ml/kg pbw
No interventions assigned to this group
phase 3
patients ventilated with a tidal volume of 8ml/kg pbw
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. diagnosis of moderate to severe ARDS no more than 72 hours
Exclusion Criteria
2. Contraindications to EIT (e.g., active implantable device, chest malformation, unstable spinal injuries or fractures, and open chest wounds)
3. Undrained pneumothorax or pneumomediastinum,
4. Hemodynamic instability
5. Pregnancy
6. Refusal by family or the attending physician to participate in the study.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southeast University, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ling Liu
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongda Hospital, School of Medicine, Southeast University
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3D-EIT perfusion
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.